PriceTargets.com logo

Yield10 Bioscience - YTEN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.33 As of 12/23/2024 01:00 AM ET
▼ -0.002 (-0.60%)

This chart shows the closing price for YTEN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Yield10 Bioscience Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YTEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YTEN

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Yield10 Bioscience in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.33.

This chart shows the closing price for YTEN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 contributing investment analysts is to hold stock in Yield10 Bioscience. This rating has held steady since January 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/8/2024Lake Street CapitalDowngradeBuy ➝ Hold
11/16/2023Maxim GroupReiterated RatingBuy ➝ Hold
11/16/2023HC WainwrightReiterated RatingBuy ➝ Buy$96.00
8/17/2023HC WainwrightLower TargetBuy ➝ Buy$600.00 ➝ $96.00
8/16/2023Lake Street CapitalLower TargetBuy ➝ Buy$288.00 ➝ $72.00
5/3/2022Univest SecInitiated CoverageBuy
4/21/2022Lake Street CapitalInitiated CoverageBuy$288.00
3/10/2022Maxim GroupLower TargetBuy$432.00 ➝ $216.00
2/9/2021Maxim GroupBoost TargetBuy$288.00 ➝ $576.00
9/10/2020HC WainwrightInitiated CoverageBuy$600.00
8/27/2020National SecuritiesUpgradeNeutral ➝ Buy$360.00
8/13/2020Maxim GroupReiterated RatingBuy$288.00
5/15/2020Maxim GroupReiterated RatingBuy$288.00
5/15/2020National SecuritiesReiterated RatingHold$240.00
3/20/2020National SecuritiesReiterated RatingHold
(Data available from 12/26/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/30/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Yield10 Bioscience logo
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Read More

Today's Range

Now: $0.33
Low: $0.32
High: $0.36

50 Day Range

MA: $0.52
Low: $0.24
High: $1.00

52 Week Range

Now: $0.33
Low: $0.31
High: $17.26

Volume

1,110 shs

Average Volume

78,164 shs

Market Capitalization

$244.42 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48

Frequently Asked Questions

What sell-side analysts currently cover shares of Yield10 Bioscience?

The following sell-side analysts have issued reports on Yield10 Bioscience in the last year: Lake Street Capital.
View the latest analyst ratings for YTEN.

What is the current price target for Yield10 Bioscience?

0 Wall Street analysts have set twelve-month price targets for Yield10 Bioscience in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Yield10 Bioscience in the next year.
View the latest price targets for YTEN.

What is the current consensus analyst rating for Yield10 Bioscience?

Yield10 Bioscience currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in YTEN, but not buy more shares or sell existing shares.
View the latest ratings for YTEN.

What other companies compete with Yield10 Bioscience?

Other companies that are similar to Yield10 Bioscience include African Agriculture, African Agriculture, CEA Industries, Edible Garden and Kalera Public. Learn More about companies similar to Yield10 Bioscience.

How do I contact Yield10 Bioscience's investor relations team?

Yield10 Bioscience's physical mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company's listed phone number is (617) 583-1700 and its investor relations email address is [email protected]. The official website for Yield10 Bioscience is www.yield10bio.com. Learn More about contacing Yield10 Bioscience investor relations.